News
-
-
-
REGULATED PRESS RELEASE
Disclosure of transactions in own shares from April 14 to April 17, 2025
-
PRESS RELEASE
Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers
Valneva provides update on ACIP recommendation for its chikungunya vaccine IXCHIQ® among U.S. travelers, highlighting new precaution for persons aged 65 years and ongoing safety monitoring -
-
-
-
-
-